Optimal growth conditions for the determination of the antifungal susceptibility of three species of dermatophytes with the use of a microdilution method

Journal of the American Academy of Dermatology

Volumn 40, Issue 6 II, 1999, Pages S9-

  Norris, H A ^a   Elewski, B E ^a   Ghannoum, M A ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; BICARBONATE; FLUCONAZOLE; GLUCOSE; GLUTAMINE; GRISEOFULVIN; ITRACONAZOLE; NITROGEN; TERBINAFINE;

CONFERENCE PAPER; CONTROLLED STUDY; CULTURE MEDIUM; DERMATOPHYTE; DILUTION; DRUG SENSITIVITY; FUNGUS CULTURE; FUNGUS GROWTH; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; TRICHOPHYTON MENTAGROPHYTES; TRICHOPHYTON RUBRUM; TRICHOPHYTON TONSURANS;

EID: 0033039465     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(99)70392-0     Document Type: Conference Paper

References (6)

1. National Committee for Clinical Laboratory Standards Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard vol. 17 1996 M27-A No. 9
2. JL. Lesher Therapeutic agents for dermatologic fungal diseases BE Elewski Cutaneous fungal infections. 1992 : Igaku-Shoin New York 229 241
3. JH Rex MA Pfaller JN Galgiani MS Bartlett A Espinel-Ingroff MA Ghannoum Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and Candida infections Clin Infect Dis 24 1997 235 247
4. DH. Larone Medically important fungi: a guide to identification 3rd ed 1995 : ASM Press Washington, DC
5. WL Epstein VP Shah S. Riegelman Griseofulvin levels in stratum corneum Arch Dermatol 106 1972 344 348
6. J Faergemann H Zehender L. Millerioux Levels of terbinafine in plasma, stratum corneum, dermis-epidermis (without stratum corneum), sebum, hair and nails during and after 250 mg terbinafine orally once daily for 7 and 14 days Clin Exp Dermatol 19 1994 121 126